LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
Stock data | 2023 | Change |
---|---|---|
Price | $10.14 | N/A |
Market Cap | $127.33M | N/A |
Shares Outstanding | 12.56M | -2.55% |
Employees | 248.00 | N/A |
Shareholder Equity | 34.65M | 9.94% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 50.70 | N/A |
P/S Ratio | 0.60 | N/A |
P/B Ratio | 3.67 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0733 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $213.40M | N/A |
Earnings | $2.54M | N/A |
EPS | 0.2 | N/A |
Earnings Yield | 0.0197 | N/A |
Gross Margin | 0.7967 | N/A |
Operating Margin | 0.02 | N/A |
Net income margin | 0.0119 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $66.12M | N/A |
Total Debt | $13.09M | N/A |
Cash on Hand | $21.61M | N/A |
Debt to Equity | 0.9084 | -26.95% |
Cash to Debt | $1.65 | 28.82% |
Current Ratio | $2.26 | 23.74% |